Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
Graziella Pompei, Cardiologist at Romagna Local Health Authority, PHD Student at University of Ferrara, shared on LinkedIn:
”Is aspirin still a valid alternative to clopidogrel in the context of double antithrombotic therapy (antiplatelet plus OAC) in patients requiring chronic OAC undergoing PCI with DES implantation?
Our post-hoc analysis of the PERSEO registry, available online on Journal of Thrombosis and Thrombolysis and presented at the EuroPCR 2026 Congress, aimed to address this question.”
Title: Clopidogrel vs. aspirin in addition to oral anticoagulation as part of double antithrombotic therapy following PCI: a post-hoc analysis of the PERSEO registry
Authors: Andrea Rubboli, Graziella Pompei, Salvatore De Rosa, Paolo Calabrò, Carolina Moretti, Bernardo Cortese, Mauro Colletta, Vanessa Porretta, Giuseppe Andò, Alessandro Sciahbasi
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 12, 2026, 11:51Daniel Sop: Sickle Cell Research Takes Center Stage at ASCAT 2026
-
Oct 12, 2026, 10:36PAI-1 Inhibition as a New Strategy for Enhancing Fibrinolysis and Clot Resolution
-
Oct 12, 2026, 07:39Emmanuel J Favaloro: 100 Years of von Willebrand Disease and the Importance of Local Diagnosis and Management
-
Oct 12, 2026, 07:39Post-Stroke Fatigue Trajectories – 38% Recovered at 12 Months, While 16% Developed New Fatigue – International Journal of Stroke
-
Oct 12, 2026, 07:28Beth Sara: IBMS Specialist Portfolio Achievement and a New Role in Transfusion Practice
-
Oct 12, 2026, 07:28Abdul Mannan: PCC vs. aPCC – The Small ‘a’ That Changes Emergency Management
-
Oct 12, 2026, 07:20Mokhtar Tazik: Improving Access to Plasma Derived Medicines Through Awareness, Interest and Accessibility
-
Oct 12, 2026, 07:08Larissa Chastain: Partnering to Transform Anticoagulation Management Through INR Self-Testing
-
Oct 12, 2026, 06:57Saiful Islam: Laboratory Spot Check – Microcytic Anemias and The Thalassemia Spectrum